Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors.
D015074:2-Aminoadipic Acid / Q000494:pharmacology; D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects; D006152:Cyclic GMP / Q000378:metabolism; D005971:Glutamates / Q000378:metabolism*; D006624:Hippocampus / Q000187:drug effects; D007608:Kainic Acid / Q000494:pharmacology*; D008297:Male; D051379:Mice; D016202:N-Methylaspartate; D011759:Pyrrolidines / Q000494:pharmacology*; D011956:Receptors, Cell Surface / Q000187:drug effects; D017470:Receptors, Glutamate; D017981:Receptors, Neurotransmitter / Q000187:drug effects*
D005971:Glutamates; D011759:Pyrrolidines; D011956:Receptors, Cell Surface; D017470:Receptors, Glutamate; D017981:Receptors, Neurotransmitter; D015074:2-Aminoadipic Acid; D001224:Aspartic Acid; D016202:N-Methylaspartate; D006152:Cyclic GMP; D007608:Kainic Acid; D002118:Calcium